Appili Therapeutics Stock Forward View - Accumulation Distribution
| APLI Stock | CAD 0.02 0.01 33.33% |
The forecast reference data for Appili Therapeutics on this page is generated using Accumulation Distribution applied to historical price observations. Projected values and error measures are included as reference material.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume The Accumulation Distribution reference values for Appili Therapeutics are derived from publicly available price data and should be used for informational purposes only. Accumulation Distribution Analysis Today
Appili Therapeutics has current Accumulation Distribution of 0.25. The accumulation distribution (A/D) indicator shows the degree to which Appili Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Appili Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Appili Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 5385.75 | 0.25 |
| Volatility | Backtest | Information Ratio |
Appili Therapeutics Trading Date Momentum
| On March 19 2026 Appili Therapeutics was traded for 0.02 at the closing time. The highest price during the trading period was 0.02 and the lowest recorded bid was listed for 0.01 . There was no trading activity during the period 0.0. Lack of trading volume on March 19, 2026 did not affect price variability. The overall trading delta to the current price is -25.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Appili Therapeutics to competition |
Other Forecasting Options for Appili Therapeutics
Investors at all stages of experience who consider Appili must develop an understanding of Appili Therapeutics' price dynamics. The noise embedded in Appili Stock price charts can create misleading signals and skew investment decisions.Appili Therapeutics Related Equities
The following equities are related to Appili Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Appili Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Appili Therapeutics Market Strength Events
Market strength indicators applied to Appili Therapeutics stock give investors a structured view of the security's momentum relative to the overall market. Using these indicators, traders can refine their timing when entering or exiting positions in Appili Therapeutics.
Appili Therapeutics Risk Indicators
Evaluating Appili Therapeutics' risk indicators is an important step in accurately forecasting its price and assessing the suitability of an investment. Understanding the risk profile of Appili Therapeutics' allows investors to make more informed decisions about position sizing and risk.
| Mean Deviation | 6.95 | |||
| Semi Deviation | 8.66 | |||
| Standard Deviation | 12.6 | |||
| Variance | 158.83 | |||
| Downside Variance | 469.44 | |||
| Semi Variance | 75.01 | |||
| Expected Short fall | -25.93 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Appili Therapeutics
Story coverage around Appili Therapeutics often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. A disciplined read of coverage helps investors separate durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Appili Therapeutics Short Properties
Reviewing short-oriented indicators for Appili Therapeutics is useful because long and short participants often create very different signals for timing and volatility. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 121.3 M | |
| Cash And Short Term Investments | 1.2 M |
More Resources for Appili Stock Analysis
Other Information on Investing in Appili Stock
Appili Therapeutics financial ratios help frame valuation context across profits, cash flow, and enterprise value. They help compare Appili across measures in a consistent way.